TMDX
TransMedics Group, Inc.
Key Financials
Gross Profit
$362.8M
↑ 38.4%
Net Income
$190.3M
↑ 436.6%
Operating Income
$108.6M
↑ 189.6%
Revenue
$605.5M
↑ 37.1%
EPS (Diluted)
$4.87
↑ 382.2%
Total Assets
$1.1B
↑ 32.9%
Total Liabilities
$595.3M
↑ 3.4%
Shareholders' Equity
$473.1M
↑ 107.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 5/7/2026 | View on SEC |
| 10-Q | 5/5/2026 | View on SEC |
| 8-K | 5/5/2026 | View on SEC |
| SCHEDULE 13G | 4/30/2026 | View on SEC |
| SCHEDULE 13G | 4/29/2026 | View on SEC |
| ARS | 4/10/2026 | View on SEC |
| DEFA14A | 4/10/2026 | View on SEC |
| DEF 14A | 4/10/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 3 | 3/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TMDX |
| Company Name | TransMedics Group, Inc. |
| CIK | 1756262 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | MA |
| Phone | 9785520900 |